NCT00024180View on ClinicalTrials.gov

FR901228 in Treating Patients With Hematologic Cancer

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

January 31, 2002

Study Completion Date

August 31, 2006

Conditions
LeukemiaLymphoma
Interventions
DRUG

romidepsin

Trial Locations (1)

43210-1240

Arthur G. James Cancer Hospital - Ohio State University, Columbus

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Ohio State University Comprehensive Cancer Center

OTHER

NCT00024180 - FR901228 in Treating Patients With Hematologic Cancer | Biotech Hunter | Biotech Hunter